Literature DB >> 15668787

Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas.

Anna Sjödin1, Dongsheng Guo, Morten Lund-Johansen, Bård Kronen Krossnes, Peer Lilleng, Roger Henriksson, Håkan Hedman.   

Abstract

Secretoglobins are small secreted proteins, the expression of which has mostly been associated with secretory mucosal epithelia. Several secretoglobins have been implicated in the development of various human cancers. Allelic deletions of chromosome 11q13 correlates with the invasiveness of pituitary tumors. Intriguingly, several secretoglobin genes are located on 11q13; however, for most of these genes the expression in the pituitary and pituitary tumors have not been investigated. Antibodies specific for the secretoglobin lipophilin B (SCGB1D2, BU101) were developed and used in an immunohistochemical analysis of a human normal tissue microarray. Prominent lipophilin B immunoreactivity was found in the secretory cells of the anterior pituitary. Eight of nine analyzed pituitary adenomas showed a reduction in lipophilin B immunoreactivity compared to normal pituitary. However, there was no apparent association between lipophilin B immunoreactivity and hormone production or tumor invasiveness. Expression of eight different secretoglobin mRNAs were analyzed in normal pituitary and the pituitary adenoma cell line HP75 by highly specific quantitative real-time reverse transcription-PCR assays. Lipophilins B and C (SCGB2A1, mammaglobin B) were the most prominently expressed secretoglobin mRNAs in the pituitary. No secretoglobin mRNA was detected in the HP75 cells. The present report demonstrates, for the first time, lipophilin B expression in the pituitary and its apparent down-regulation in pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668787     DOI: 10.1007/s00401-004-0972-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  5 in total

1.  Evaluation of lipophilins as determinants of tumor cell response to estramustine.

Authors:  Jody M Tucker; Zhanna Lipatova; Vladimir Beljanski; Danyelle M Townsend; Kenneth D Tew
Journal:  J Pharmacol Exp Ther       Date:  2005-08-24       Impact factor: 4.030

Review 2.  Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily.

Authors:  Brian C Jackson; David C Thompson; Mathew W Wright; Monica McAndrews; Alfred Bernard; Daniel W Nebert; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

3.  Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.

Authors:  Menelaos Zafrakas; Beate Petschke; Andreas Donner; Florian Fritzsche; Glen Kristiansen; Ruth Knüchel; Edgar Dahl
Journal:  BMC Cancer       Date:  2006-04-09       Impact factor: 4.430

4.  Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.

Authors:  Renata A Tassi; Stefano Calza; Antonella Ravaggi; Eliana Bignotti; Franco E Odicino; Germana Tognon; Carla Donzelli; Marcella Falchetti; Elisa Rossi; Paola Todeschini; Chiara Romani; Elisabetta Bandiera; Laura Zanotti; Sergio Pecorelli; Alessandro D Santin
Journal:  BMC Cancer       Date:  2009-07-27       Impact factor: 4.430

5.  Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.

Authors:  Eliana Bignotti; Renata A Tassi; Stefano Calza; Antonella Ravaggi; Elisa Rossi; Carla Donzelli; Paola Todeschini; Chiara Romani; Elisabetta Bandiera; Laura Zanotti; Mario Carnazza; Francesco Quadraro; Germana Tognon; Enrico Sartori; Sergio Pecorelli; Dana M Roque; Alessandro D Santin
Journal:  J Transl Med       Date:  2013-07-02       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.